Zurueck zur Suche

Reporte zur Charge UJ474AAA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

5Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 2 CA 1 OK 1 CO 1

VAERS 1766320

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ474AAA

mild
Staat
CA
Alter
0,2
Geschlecht
F
Eingang
06.10.2021
Impfdatum
21.09.2021
Beginn
22.09.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash Rash erythematous Rash pruritic

Symptomtext

This is a new problem. Episode onset: 9 days ago (24h after receiving the 2mo vaccines: Pentacel, Hep B, Rotavirus and Prevnar) The onset was sudden. The problem occurs continuously. The problem has been gradually improving. The rash is present on the abdomen, face, back, left upper leg and left arm. The problem is moderate. The rash is characterized by itchiness and redness. Associated with: 2mo immunizations. The rash first occurred at home. Pertinent negatives include no anorexia, no decrease in physical activity, not sleeping less, not drinking less, no fever, no fussiness, not sleeping more, no diarrhea, no vomiting, no congestion, no rhinorrhea, no sore throat, no decreased responsiveness and no cough. Her past medical history does not include atopy in family. There were no sick contacts. Mother denies animals at home, new detergent, new formula or food intake. Child did not have any reaction when she received Hep B vaccine as a newborn.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
No labs were ordered during provider visit 10/01/2021.
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2465799

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ474AAA

gering
Staat
OK
Alter
3,0
Geschlecht
M
Eingang
30.09.2022
Impfdatum
29.09.2022
Beginn
29.09.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

administered expired vaccine to patient. Vaccine rep notified, parents notified. no adverse reaction noted by parents. 09/30/2022 parents do not express any concerns at this time. plan to revaccinate in 28 days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2415730

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ474AAA

gering
Staat
TX
Alter
3,0
Geschlecht
M
Eingang
19.08.2022
Impfdatum
12.08.2022
Beginn
12.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Medication error No adverse event

Symptomtext

expired dose of pentacel administered to a patient with no reported adverse event; Initial information received on 15-Aug-2022 regarding an unsolicited valid non-serious case received from a physician. This case involves a 3 years old male patient who was administered expired dose of diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine [Pentacel] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included VARICELLA ZOSTER VACCINE (VARICELLA VACCINE) for Prophylactic vaccination; MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE (MMR) for Prophylactic vaccination; PNEUMOCOCCAL VACCINE CONJ (PNEUMOCOCCAL CONJUGATE VACCINE) for Prophylactic vaccination; and HEPATITIS A VACCINE (HEPATITIS A) for Prophylactic vaccination. On 12-Aug-2022, the patient received 0.5 mL dose of suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine (formulation and strength not reported; lot UJ474AAA, expiry date: 09-Jul-2022) via intramuscular route in the thigh nos for immunization. On 12-Aug-2022, the patient was administered expired dose of diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine with no reported adverse event (expired product administered). It was reported, "an expired dose of PENTACEL administered to a patient. Requesting validity information. This situation is reported as a medication error due to expired dose of PENTACEL being administered". Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2277669

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ474AAA

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
14.05.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

medication error due to administration after a possible temperature excursion with no reported adverse event; Initial information received on 03-May-2022 regarding an unsolicited valid non-serious case received from a healthcare professional. This case is linked to case IDs 2022SA161486 and 2022SA159339. This case involves medication error due to administration of pentacel to 3 infants after a possible temperature excursion with no reported adverse event involving the vaccines IPV (vero) [ipol] and diphtheria/tetanus/5 hybrid AC PERTUSSIS/IPV(mrc5)/HIB(PRP/T) vaccine [pentacel]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date 3 dosage forms (DF) of diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine (Batch number: UJ474AAA) were administered to 3 infants and one dosage form of IPV (vero) (batch number: unknown) after a possible temperature excursion with no reported adverse event (product storage error) (latency: unknown) (formulation, strength, route, administration site expiry date unknown for both vaccines). It was reported that "Vaccine Compliance Officer called for guidance. She had unpunctured IPOL x5 and unopened Pentacel x3 and fluzone QIV (caller could not confirm presentation of FLUZONE) x1. Caller states due to a change in staffing and this "being a high-profile case" no temperature data has been taken since 1-Feb-2022. Caller stated before that date the temperatures were known to be in recommended range. Since no temperatures could be given, no stability information could be given. Caller was requesting information on whom to reach out to next for more information. Caller requests callback. Outbound Call to caller made at 3:45pm, where caller was directed to the CDC Vaccines Storage Handling Toolkit for further direction regarding her vaccines. Upon this outbound call, caller informs agent that 1 dose of IPOL was administered, 3 doses of Pentacel were administered and 1 dose of Fluzone QIV was administered. Caller provided information regarding the vaccines being unopened that could be inconsistent with the information provided regarding the administration to patients. Caller was unable to give most safety report information due to the "high priority status of this case". This reports AEs for potential administration following a temperature excursion regardless." Action taken: Not applicable with both suspects. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2177099

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ474AAA

gering
Staat
TX
Alter
0,7
Geschlecht
F
Eingang
12.03.2022
Impfdatum
07.10.2021
Beginn
01.03.2022
Tage bis Beginn
145,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Medication error

Symptomtext

Administered the 3rd dose of Pentacel 9 days too soon with no reported adverse event; Initial information received received on 02-Mar-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 8 months old female patient who was administered the 3rd dose of pentacel 9 days too soon with no reported adverse event while receiving vaccine Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(MRC5)/HIB(PRP/T) Vaccine [Pentacel]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 07-Oct-2021, the patient received a first dose (dose-1) and on 10-Feb-2022 the patient received a second dose (dose-2) (dosage, form, route, administration site, strength: unknown); the patient received a third dose (3rd dose) 01-Mar-2022 of suspect Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(MRC5)/HIB(PRP/T) Vaccine (dose 0.5 ml to 2 ml via intramuscular route in left thigh); all with lot UJ474AAA and expiry date 09-Jul-2022 for prophylactic vaccination. On 01-Mar-2022 the patient was administered the 3rd dose of pentacel 9 days too soon with no reported adverse event (inappropriate schedule of product administration) (latency: same day). Action taken was not applicable Outcome was Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-